Albumin nanoparticles for the delivery of gabapentin: Preparation, characterization and pharmacodynamic studies

International Journal of Pharmaceutics

Volumn 473, Issue 1-2, 2014, Pages 73-79

  Wilson, Barnabas ^a   Lavanya, Y ^a   Priyadarshini, S R B ^a   Ramasamy, Muthu ^b   Jenita, Josephine Leno ^a  

^a Kumarswamy Layout   (India)

^b SASTRA UNIVERSITY   (India)

Author keywords

Albumin nanoparticles; Brain drug targeting; Convulsion; Gabapentin

Indexed keywords

ALBUMIN; GABAPENTIN; NANOPARTICLE; POLYSORBATE 80; 4 AMINOBUTYRIC ACID; AMINE; ANTICONVULSIVE AGENT; BOVINE SERUM ALBUMIN; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; DRUG CARRIER; PENTETRAZOLE; POLYSORBATE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; CONVULSION; DRUG BRAIN LEVEL; DRUG DELIVERY SYSTEM; DRUG RELEASE; IN VITRO STUDY; MALE; NONHUMAN; PARTICLE SIZE; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; ZETA POTENTIAL; ANIMAL; CHEMISTRY; DISEASE MODEL; DRUG FORMULATION; ELECTRIC SHOCK; METABOLISM; SEIZURES; WISTAR RAT;

AMINES; ANIMALS; ANTICONVULSANTS; BRAIN; CYCLOHEXANECARBOXYLIC ACIDS; DISEASE MODELS, ANIMAL; DRUG CARRIERS; DRUG COMPOUNDING; ELECTROSHOCK; GAMMA-AMINOBUTYRIC ACID; MALE; NANOPARTICLES; PENTYLENETETRAZOLE; POLYSORBATES; RATS, WISTAR; SEIZURES; SERUM ALBUMIN, BOVINE;

EID: 84904792690     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.05.056     Document Type: Article

References (36)

1. P. Costa, and J.M.S. Lobo Modeling and comparison of dissolution profiles Eur. J. Pharm. Sci. 13 2001 123 133
2. N. Desai, V. Trieu, Z. Yao, L. Louie, S. Ci, A. Yang, C. Tao, T. De, B. Beals, D. Dykes, P. Noker, R. Yao, E. Labao, M. Hawkins, and P. Soon-Shiong Increased antitumour activity, intratumour paclitaxel, concentrations, and endothelial cell transport of cremophor-free, albumin bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel Clin. Cancer Res. 12 2006 1317 1324
3. A. des Rieux, V. Fievez, M. Garinot, Y.J. Schneider, and V. Preat Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach J. Control. Release 116 2006 1 27
4. A. Friese, E. Seiller, G. Quack, B. Lorenz, and J. Kreuter Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system Eur. J. Pharm. Biopharm. 49 2000 103 109
5. B.E. Gidal, L.L. Radulovic, S. Kruger, P. Rutecki, M. Pitterle, and H.N. Bockbrader Inter and intra-subject variability in gabapentin absorption and absolute bioavailability Epilepsy Res. 40 2000 123 127
6. G.V. Goddard, D.C. McIntyre, and C.K. Leech A permanent change in brain function resulting from daily electrical stimulation Exp. Neurol. 25 1969 295 330
7. W.J. Gradishar, S. Tjulandin, N. Davidson, H. Shaw, N. Deasi, P. Bhar, M. Hawkins, and J. O'Shaughnessy Phase III trial of nanoparticles albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer J. Clin. Oncol. 23 2005 7794 7803
8. B. Hermann, M. Seidenberg, and J. Jones The neurobehavioural comorbidities of epilepsy: can a natural history be developed? Lancet Neurol. 7 2008 151 160
9. L. Illum, S.S. Davis, C.G. Wilson, N.W. Thomas, M. Frier, and J.G. Hardy Blood clearance and organ deposition of intravenously administered colloidal particles. The effects of particle size, nature and shape Int. J. Pharm. 12 1982 135 146
10. D.S. Kohane, J.Y. Tse, Y. Yeo, R. Padera, M. Shubina, and L. Robert Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum J. Biomed. Mater. Res. A 77A 2006 351 361
11. J. Kreuter, P. Ramge, V. Petrov, S. Hamm, S.E. Gelperina, B. Engelhardt, R.N. Alyautdin, H. von Briesen, and D.J. Begley Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanism requiring prior binding of drugs to the nanoparticles Pharm. Res. 20 2003 409 416
12. J. Kreuter, T. Hekmatara, S. Dreis, T. Vogel, S. Gelperina, and K. Langer Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain J. Control. Release 118 2007 54 58
13. P. Kwan, G.J. Sills, and M.J. Brodie The mechanisms of action of commonly used antiepileptic drugs Pharmacol. Ther. 90 2001 21 34
14. C.J. Landmark, S.I. Johannessen, and T. Tomson Host factors affecting antiepileptic drug delivery-pharmacokinetic variability Adv. Drug Deliv. Rev. 64 2012 896 910
15. W. Lin, A.G.A. Coombes, M.C. Davies, S.S. Davis, and L. Illum Preparation of sub-100 nm human serum albumin nanospheres using a pH-coaervation method J. Drug Target. 1 1993 237 243
16. R. Löbenberg, L. Araujo, H. von Brisen, E. Rodgers, and J. Kreuter Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats J. Control. Release 50 1998 21 30
17. R.M. Mainardes, and R.C. Evangelista PLGA nanoparticles containing praziquantel effect of formulation variables on size distribution Int. J. Pharm. 290 2005 144
18. B.S. Meldrum GABA agonists as antiepileptic agents Adv. Biochem. Psychopharmacol. 26 1981 207 217
19. K. Michaelis, M.M. Hoffmann, S. Dreis, E. Herbert, R.N. Alyautdin, M. Michaelis, J. Kreuter, and K. Langer Covalent linkage of apolipoprotein E to albumin nanoparticles strongly enhances drug transport into the brain J. Pharm. Exp. Ther. 317 2006 1246 1253
20. G. Rajtar, D. Zolkowska, G. Czechwska, and Z. Kleinrok Effects of antiepileptic drugs on rat platelet aggregation: ex vivo and in vitro study Epilepsy Res. 43 2001 59 66
21. C. Roney, P. Kulkarni, V. Arora, P. Antich, F. Bonte, A. Wu, N.N. Mallikarjuana, S. Manohar, H.-F. Liang, A.R. Kulkarni, and H.-W. Sung Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease J. Control. Release 108 2005 193 214
22. Z.-Y. Shen, G.-H. Ma, T. Dobashi, Y. Maki, and Z.-G. Su Preparation and characterization of thermo-responsive albumin nanospheres Int. J. Pharm. 346 2008 133 142
23. B.H. Stewart, A.R. Kugler, P.R. Thompson, and H.N. Bockbrader A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of lack of proportionality between increasing dose and drug level in plasma Pharm. Res. 10 1993 27 281
24. E.A. Swinyard, W.C. Brown, and L.S. Goodman Comparative assays of antiepileptic drugs in mice and rats J. Pharmacol. Exp. Ther. 106 1952 319 330
25. S.D. Tröster, U. Miiller, and J. Kreuter Modification of the body distribution of poly(methylmethacrylate) nanoparticles in rats by coating with surfactants Int. J. Pharm. 61 1990 85 100
26. J. Varshosaz, S. Ghaffari, M.R. Khoshayand, F. Atyabi, S. Azarmi, and F. Kobarfard Development and optimization of amikacin solid lipid nanoparticles by central composite design J. Liposome Res. 20 2010 97 104
27. K.O. Vollmer, A. von Hodenberg, and E.U. Kolle Pharmacpkinetics and metabolism of gabapentin in rat, dog and man Arzneim. Forsch. Drug Res. 36 1988 830 839
28. B. Wilson Brain targeting PBCA nanoparticles and the blood-brain barrier Nanomedicine (Lond.) 4 2009 499 502
29. B. Wilson Therapeutic compliance of nanomedicine in Alzheimer's disease Nanomedicine (Lond.) 6 2011 1137 1139
30. B. Wilson, M.K. Samanta, K. Santhi, K.P. Sampathkumar, N. Paramakrishnan, and B. Suresh Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles Eur. J. Pharm. Biopharm. 70 2008 75 84
31. B. Wilson, M.K. Samanta, K. Santhi, K.P. Sampathkumar, N. Paramakrishnan, and B. Suresh Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease Brain Res. 1200 2008 159 168
32. B. Wilson, M.K. Samanta, K. Santhi, K.P. Sampathkumar, M. Ramasamy, and B. Suresh Chitosan nanoparticles as a novel delivery system for anti-Alzheimer's drug tacrine Nanomedicine 6 2010 144 152
33. B. Wilson, M.K. Samanta, and B. Suresh Design and evaluation of chitosan nanoparticles as novel drug carrier for the delivery of rivastigmine to treat Alzheimer's disease Ther. Deliv. 2 2011 599 609
34. B. Wilson, T.V. Ambika, P. Dharmeshkumar, J.J.L. Jenita, and S.R.B. Priyadarshini Nanoparticles based on albumin: preparation, characterization and the use for 5-flurouracil delivery Int. J. Biol. Macromol. 51 2012 874 878
35. J.-A. Witt, and C. Helmstaedter Monitoring the cognitive effects of antiepileptic pharmacotherapy - approaching the individual patient Epilepsy Behav. 26 2013 450 456
36. S.Y. Xie, S.L. Wang, B.K. Zhao, C. Han, M. Wang, and W.Z. Zhou Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein loaded solid lipid nanoparticles Colloids Surf. B Biointerfaces 67 2008 199 204